Comparative study of the efficacy of eprinomectin versus ivermectin, and field efficacy of eprinomectin only, for the treatment of chorioptic mange in alpacas.

Author: D'AlterioG L, FosterA P, JacksonA P, KnowlesT G

Paper Details 
Original Abstract of the Article :
The efficacy of eprinomectin versus ivermectin (Study 1: a single-centre, randomised, treatment-controlled, blinded field trial), and the field efficacy of eprinomectin (Study 2: a single-centre, open, un-controlled field trial) for the treatment of chorioptic infestation in naturally infested alpac...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.vetpar.2005.03.036

データ提供:米国国立医学図書館(NLM)

Eprinomectin Versus Ivermectin: A Comparative Desert Trek

Chorioptic mange, a skin infestation in alpacas, can be a troublesome condition. This comparative study evaluates the effectiveness of eprinomectin and ivermectin in treating chorioptic mange in alpacas. The researchers, like skilled explorers charting different paths through a desert, compared the efficacy of these two medications. Their findings suggest that eprinomectin, administered topically in four weekly doses, was highly effective in reducing the chorioptic mite burden in alpacas, offering a potentially superior treatment option.

Eprinomectin: A More Effective Desert Trek

This study found that eprinomectin, administered topically in four weekly doses, proved highly effective in reducing the chorioptic mite burden in alpacas, outperforming ivermectin. It's like finding a smoother and more efficient path through a challenging desert landscape, leading to a faster and more successful outcome.

Keeping Alpaca Skin Healthy

This research provides valuable insights for veterinarians treating chorioptic mange in alpacas, suggesting that eprinomectin may be a more effective treatment option. It highlights the importance of choosing the right medication and treatment regimen to ensure optimal outcomes for these furry companions. Think of it like a desert traveler selecting the best route for a safe and successful journey, ensuring the well-being of their camel and themselves.

Dr.Camel's Conclusion

This study suggests that eprinomectin, administered topically in four weekly doses, may be a more effective treatment option for chorioptic mange in alpacas compared to ivermectin. It's like finding a more efficient and direct path through a challenging desert landscape, leading to better outcomes for the alpaca's health and well-being.

Date :
  1. Date Completed 2005-08-08
  2. Date Revised 2016-11-24
Further Info :

Pubmed ID

15890448

DOI: Digital Object Identifier

10.1016/j.vetpar.2005.03.036

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.